MedPath
TGA Approval

SETRELVO ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe (422773)

422773

SETRELVO ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe

Janssen-Cilag Pty Ltd

July 22, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Ustekinumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SETRELVO ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe (422773) - TGA 批准文号 | MedPath